This HTML5 document contains 57 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
n6http://en.wikipedia.org/wiki/List_of_drugs:_Im%E2%80%93
n12http://en.wikipedia.org/wiki/Category:Merck_&_Co.
n10http://en.wikipedia.org/wiki/Category:
skoshttp://www.w3.org/2004/02/skos/core#
n17http://caligraph.org/ontology/Johnson_&
rdfshttp://www.w3.org/2000/01/rdf-schema#
n18http://caligraph.org/ontology/Merck_&_Co.
n11http://en.wikipedia.org/wiki/Merck_&_Co.
n4http://caligraph.org/ontology/Drug:
n16http://en.wikipedia.org/wiki/List_of_drugs:
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://en.wikipedia.org/wiki/Category:Johnson_&
owlhttp://www.w3.org/2002/07/owl#
clgohttp://caligraph.org/ontology/
n7http://en.wikipedia.org/wiki/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
dbrhttp://dbpedia.org/resource/
clgrhttp://caligraph.org/resource/
Subject Item
clgr:Hubert_Schoemaker
clgo:knownFor
clgr:Infliximab
Subject Item
clgr:Janssen_Biotech
clgo:product
clgr:Infliximab
Subject Item
clgr:Celltrion
clgo:product
clgr:Infliximab
Subject Item
clgr:Checkpoint_inhibitor_induced_colitis
clgo:treatment
clgr:Infliximab
Subject Item
clgr:Infliximab
rdf:type
clgo:Therapeutic_monoclonal_antibody n4:_Re owl:NamedIndividual clgo:Schering-Plough_brand clgo:Largest_selling_pharmaceutical_product clgo:World_Health_Organization_essential_medicine clgo:Engineered_protein clgo:Monoclonal_antibody clgo:Immunosuppressant n17:_Johnson_brand clgo:TNF_inhibitor n18:_brand
rdfs:label
Infliximab
owl:sameAs
dbr:Infliximab
prov:wasDerivedFrom
n6:In n7:Drug-induced_lupus_erythematosus n7:RECOVERY_Trial n7:Monoclonal_antibody_therapy n10:Engineered_proteins n7:Disease-modifying_antirheumatic_drug n7:List_of_therapeutic_monoclonal_antibodies n11: n10:Monoclonal_antibodies n10:Schering-Plough_brands n10:Immunosuppressants n12:_brands n7:List_of_largest_selling_pharmaceutical_products n7:Psoriatic_onychodystrophy n7:Schering-Plough n10:World_Health_Organization_essential_medicines n13:_Johnson_brands n10:TNF_inhibitors n7:Fine_chemical n7:Collagenous_colitis n16:_Re n7:Etanercept n7:Biosimilar n7:Serum_sickness n7:Biopharmaceutical n7:Antiarthritics n7:Drug-induced_aseptic_meningitis
skos:prefLabel
Infliximab
skos:altLabel
Remicade Inflixamab infliximab
clgo:alternativeName
Remicade, others
clgo:bioavailability
92.0
clgo:casNumber
170277-31-3
clgo:chEMBL
1201581
clgo:drugbank
DB00065
clgo:fdaUniiCode
B72HH48FLU
clgo:kegg
D02598
Subject Item
clgr:Pyoderma_gangrenosum
clgo:treatment
clgr:Infliximab